Gene Query: SLC37A2

Dataset Description Geneva Score
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 141.47
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 132.9
The pioneer factor CEBPA modulates vitamin D signaling 132.9
MicroRNA-125a-5p overexpression in human macrophages 93.52
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 85.0
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 77.97
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 77.97
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 70.23
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 70.23
Transcripotome analysis of different locations of hair follicles (bulb, bulge) in androgenetic alopecia 52.16
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 51.3
ZIKV infection of monocytes activates inflammasome pathways 49.33
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 44.26
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 42.94
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 40.41
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 38.77
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 37.49
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 36.12
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 36.12
Effects of rFVIIIFc on human macrophages 34.75
Transcriptome-wide analysis to determine miR-200a targets in melanoma cell lines 32.7
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 30.61
Parvovirus B19 NS1 protein induces cell cycle arrest at G2 phase 30.45
RNA expression following TMPRSS11B overexpression or depletion 28.98
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 28.5
RNA-seq analysis of AML cells in response to ASLAN003 28.01
Targeting MTHFD2 in Acute Myeloid Leukemia 26.54
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 26.49
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 26.03
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 25.34
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 25.34
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 25.12
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 24.74
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 24.58
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 24.22
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 23.88
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 23.88
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 22.65
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 22.56
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 22.12
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 22.11
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 22.0
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 21.97
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 21.7
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 21.23
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 21.23
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 21.22
RNA-seq of stable and unstable section of human atherosclerotic plaques 20.33
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 20.13
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 19.43
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 18.9
Generation and functional characterization of MDSC-like cells 18.77
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 18.7
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 18.41
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 18.0
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 17.48
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 17.48
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 17.32
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 17.32
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 17.32
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 17.18
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 17.18
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 16.86
Apoptotic endothelial cells release small extracellular vesicles loaded with immunostimulatory viral-like RNAs 16.75
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 16.65
Inhibition of TNBC metastasis by Gpx1 16.63
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 16.44
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 16.3
MCF10A H-Ras RNA-Seq 16.04
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  15.97
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 15.86
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 15.65
NAPRT activation of macrophages 15.58
Efficient derivation of microglia-like cells from human pluripotent stem cells 15.53
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 15.44
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 15.23
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 15.23
Effect of Hotair overexpression in human breast cancer cell lines 15.18
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 15.12
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 14.8
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 14.8
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 14.77
The evolution of N6-methyladenosine in primates 14.67
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 14.54
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 14.47
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 13.98
JunB control of keratinocyte-mediated inflammation [RNA-seq] 13.98
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 13.66
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 13.37
The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing [RNA-seq] 13.25
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 13.24
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 12.94
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 12.7
Ribosomal footprinting of MDA-Parental and MDA-LM2 12.66
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 12.66
TLR2 dimerization blockade allows generation of homeostatic intestinal macrophages under acute colitis challenge 12.61
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 12.6
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 12.59
Changes in human endometrial gland transcriptome over the window of implantation 12.59
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  12.47
Neuronal Development And The Onset Of Electrical Activity In The Human Enteric Nervous System 12.11
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 12.1
Differential gene expression of human melanoma cells [RNA-seq] 11.74
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 11.74
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 11.74
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 11.74
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 11.68
BACH2 in human plasma cell fate decision 11.62
Reassessment of Exosome Composition 11.57
RNA-seq analysis of BAP1-depleted uveal melanoma cells 11.55
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 11.47
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 11.47
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 11.45
Integrin signaling regulates YAP/TAZ to control skin homeostasis 11.4
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 11.39
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 11.38
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 11.38
Gene expression profile in breast cancer cells 11.37
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 11.37
JAG1 Mediated Notch Signaling Regulates Secretory Cell Differentiation of the Human Airway Epithelium 11.05
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 11.02
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 11.0
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 10.85
Fbxo32 mediated gene expression program underlies EMT and metastasis 10.81
Macrophage Ad5f35 PhenoMap 10.77
RNA-seq of MDA-MB-231 cells with TET1 knockout 10.68
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 10.6
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 10.58
Reprogrammed myeloid cell transcriptomes in NSCLC 10.56
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 10.49
Microglia innatly develop within cerebral organoids 10.4
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (mRNA-Seq) 10.36
A recessive form of hyper-IgE syndrome by disruption of ZNF341-dependent STAT3 transcription and activity 10.33
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 10.22
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 10.1
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 10.03
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 9.94
Virus Mimicry in the Tumor Microenvironment Activates RIG-I Through Unshielding of Endogenous RNA in Exosomes [RNA-Seq] 9.82
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 9.78
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 9.69
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 9.67
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 9.64
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 9.58
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 9.58
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 9.55
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 9.31
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 9.31
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 9.24
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 9.24
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 9.21
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 9.2
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 9.11
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 9.11
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 9.07
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 9.02
Exploring the gene expression profile upon FXR1 knockdown in H358 cells using RNA-seq 9.02
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 8.94
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 8.92
Differential Gene Expression between MCF10A and MCF7 cells 8.89
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.84
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 8.82
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 8.81
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 8.8
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 8.8
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung 8.8
Super-enhancer-driven CCAT1 is co-activated by SOX2 and TP63 and promotes squamous cancer from esophagus, head and neck and lung [RNA-seq] 8.8
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 8.71
RNA-sequencing of bulk CD19+ Thymic B cells from young (3 month - 4 year) and old (42 - 61 years) humans 8.64
RNA-sequencing of bulk CD19+ Thymic B cells from mice and humans 8.64
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 8.61
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 8.48
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 8.44
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 8.44
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 8.34
Ribosomal footprinting of CN34-Parental and CN34-LM1a 8.33
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia 8.2
LKB1, Salt-Inducible Kinases, and MEF2C are linked dependencies in acute myeloid leukemia (RNA-Seq) 8.2
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 8.18
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 8.14
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 8.02
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 8.0
AhR activity directs BRAF inhibitors resistance in metastastic melanoma 7.88
Transcriptomics analysis of human jejunal enteroendocrine cells after vertical sleeve gastrectomy 7.87
Transcriptomics analysis of enteroendocrine cells following vertical sleeve gastrectomy 7.87
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 7.85
T47D RNA-seq and ChrRNA-seq data 7.85
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 7.79
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 7.79
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 7.76
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 7.76
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 7.75
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 7.58
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 7.58
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 7.47
siRNA-mediated knockdown 7.45
HEK293 Heat-shock experiment 7.4
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 7.33
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 7.29
Gene expression changes in human melanoma cell lines compared to primary melanocytes 7.24
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 7.23
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 7.23
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 7.13
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 7.09
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 7.08
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 6.99
Transcriptomes of oxLDL exposed trained monocytes 6.89
oxLDL exposed trained monocytes 6.89
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 6.85
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 6.85
Transcriptome sequencing of differentially expressed genes in mouse and human skin with and without NCSTN mutation 6.84
Transcriptome sequencing of differentially expressed genes in acne inversa (AI) patients with NCSTN mutation and healthy individuals 6.84
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 6.82
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 6.82
RNA-seq profile of expanded human ST2-transduced Tregs cultured with IL-2 and TCR in the presence or absence of IL-33 6.82
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 6.81
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 6.8
APOBEC mutation drives early-onset squamous cell carcinomas in recessive dystrophic epidermolysis bullosa 6.75
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 6.75
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  6.64
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 6.54
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 6.49
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 6.43
Loss of endometrial plasticity in recurrent pregnancy loss 6.43
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 6.43
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 6.41
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 6.39
Paxillin regulates genomic networks in prostate cancer [PC3] 6.37
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 6.37
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 6.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 6.35
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 6.31
RNA-seq analysis of human KMT2A rearranged MV4;11 AML cell line treated with DOT1L and/or EZH2 inhibitor 6.28
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 6.19
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 6.19
Global analysis of alternative splicing regulated by RBM10 6.14
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 6.0
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 6.0
Distinct roles of cohesin-SA1 and cohesin-SA2 in 3D chromosome organization  5.96
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 5.96
RNA-Seq analysis of breast cancer cells after shikonin treatment 5.9
The effect of Abl kinases on non-small cell carcinoma global transcriptome 5.9
Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle 5.88
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 5.88
Dysregulated immune system networks in war veterans with PTSD 5.85
Comprehensive molecular phenotypic effects of the large deletion on chromosome 22q11.2 5.83
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 5.75
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 5.74
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 5.73
Downregulation of LATS kinases alters p53 to promote cell migration 5.72
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.72
MRTF activates TEAD-YAP target gene expression 5.68
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 5.65
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 5.65
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 5.62
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 5.51
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.5
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.5
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 5.49
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.47
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.47
Oncogenic MYC induces a dependency on the spliceosome in human cancer 5.46
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 5.44
Pharmacologic inhibition of STAT5 in AML 5.43
CHD1 regulates cell fate determination by activation of differentiation-induced genes 5.42
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 5.42
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 5.4
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 5.34
Cell responses to dysregulated VZV-induced cell-cell fusion 5.31
Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria 5.31
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 5.3
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 5.29
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 5.26
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 5.25
Transcriptome analysis of peripheral blood monocytes 5.22
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 5.19
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 5.16
CircRNAome diversity in human mature B-cells, T-cells and monocytes 5.13
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 5.06
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 5.02
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 4.97
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 4.95
Transcription control by the ENL YEATS domain in acute leukemia 4.95
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 4.93
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 4.93
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 4.91
Transcriptional profiles of normal human mature B cells 4.82
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 4.78
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 4.76
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 4.74
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 4.74
Transcriptomic analysis of frontal fibrosing alopecia 4.66
6mer seed toxicity in tumour suppressive microRNAs 4.63
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 4.61
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 4.56
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 4.56
HBEC-shp53-PCHD7 4.55
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 4.54
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 4.52
Exploiting drug addiction mechanisms to select against MAPKi resistant melanoma 4.44
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 4.41
MAIT cell RNA sequencing 4.37
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 4.36
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 4.36
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 4.36
Transcriptomes of human monocytes after ex vivo exposure to uric acid 4.32
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 4.3
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 4.3
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 4.24
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch Type Alopecia Areata, Totalis and Universalis 4.23
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 4.22
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 4.22
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 4.21
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state. 4.21
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 4.16
RNA sequencing of erythroid and granulomonocytic colonies differentiated from transduced bone marrow CD34+ cells expressing U2AF1 S34F mutation, U2AF1 wild-type or empty vector control 4.16
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 4.13
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 4.11
RNA-seq of healthy CD34+ HSPCs after co-culture with myelodyplastic syndrome patient-derived mesenchymal stromal cells 4.1
HEXIM1 is induced by DHODH inhibition to suppress melanoma 4.09
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 4.09
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 4.06
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 4.03
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.99
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.97
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 3.94
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 3.94
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 3.93
Fusion discovery in breast cancer cell line 3.93
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 3.92
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 3.92
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 3.91
The circadian transcriptional landscape in primary human mammary epithelial cells 3.9
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 3.85
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.83
Apatinib preferentially inhibits Gefitinib-resistant lung cancer cells by inducing cell cycle arrest and inhibiting VEGFR signaling pathway 3.78
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 3.74
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 3.74
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 3.74
Irf9 function in immunity in mouse 3.71
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 3.71
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 3.67
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 3.64
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 3.62
Genome-wide maps of transcriptomic and epigenomic state in melanoma cell lines 3.62
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 3.61
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 3.6
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 3.6
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 3.6
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 3.58
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 3.54
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 3.49
Tpl-2 small molecule project 3.46
Tpl-2 and MEK small molecule inhibitors 3.46
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 3.45
RNA-seq of MCF10A cells and CAF 3.35
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 3.35
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 3.35
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 3.34
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.32
Common inflammatory pathways between NEC and Crohn's disease 3.27
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 3.23
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.16
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.16
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.16
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 3.09
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 3.09
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 3.05
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.04
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 3.04
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.02
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 2.99
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 2.98
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.97
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 2.88
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 2.84
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 2.83
RNA-sequencing in immortalized human mammary epithelial cells 2.83
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 2.8
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 2.77
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.72
Zika virus infection reprograms global transcription of host cells to allow sustained infection 2.71
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.7
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 2.61
Anti-inflammatory effect of indoleacrylic acid (IA) 2.61
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 2.58
Fibroblasts in cholesteatoma activate osteoclasts. 2.56
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.44
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 2.39
mRNA sequencing of oropharyngeal cancer cell lines 2.37
RNA sequencing of human mammary epithelial cells 2.33
Extracellular matrix (ECM) stiffness and collagen-1 (col-1) responsive genes in 3D cultured mammary epithelial cells 2.33
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.32
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 2.32
Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms 2.29
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 2.28
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 2.25
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.24
Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma 2.19
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 2.17
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 2.16
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 2.16
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 2.14
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 2.14
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 2.11
RNA-seq of cells with TET1 knockout 2.08
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 2.05
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 2.02
Pluripotent stem cell model of Nakajo-Nishimura syndrome untangles proinflammatory pathways mediated by oxidative stress 2.01
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) [RNA-seq] 1.91
Biomarkers of Cavernous Angioma with Symptomatic Hemorrhage (CASH) 1.91
RNA m5C Methylation in breast cancer using MeRIP-Seq 1.88
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 1.87
The role of m6A/m-RNA methylation in stress response regulation 1.87
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 1.85
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.79
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.79
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.79
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 1.78
Priming mobilization of hair follicle stem cells triggers permanent loss of regeneration after alkylating chemotherapy 1.77
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.77
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 1.75
RNA-Seq of Breast and Ovarian Cancer Cell Lines 1.63
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 1.59
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.59
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 1.57
Long Non-coding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity 1.57
Gene expression of thyroid cancer cell lines 1.56
RNA-seq of CD33 KO and control HSPCs 1.43
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 1.43
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 1.42
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.39
Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia 1.27
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 1.27
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 1.26
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.21
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.17
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 [stranded] 1.14
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 1.13
Gene expression analysis of human adenomas. 1.13
Transcriptomes of human monocytes from patients with familial hypercholesterolemia before and after statin treatment 1.12
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 1.1
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.07
Ribosome profiling upon inhibition of eIF4A 1.06
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 1.06
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 1.03
BMS-470539 on human synovial fibroblasts 1.03
Transcriptomic analysis of human macrophages in 3D 1.02
RNA sequencing of human pancreatic cancer cell lines 0.95
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 0.93
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.92
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.91
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 0.89
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 0.89
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.88
RNA sequencing of bone marrow CD34+ cells from myelodysplastic syndrome patients with and without SF3B1 mutation and from healthy controls 0.88
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 0.85
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 0.81
Gene expression activation in CLL mediated by MSCs contact 0.8
Novel Atherogenic Pathways from the Differential Transcriptiome Analysis of Diabetic Epicardial Adipose Tissue 0.78
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 0.78
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 0.76
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.74
Rorc disruption in human FG pancreatic cancer cells 0.74
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.72
Pluripotent stem cell models of Blau syndrome reveal an IFN-<gamma>-dependent inflammatory response in macrophages 0.64
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 0.59
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 0.56
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 0.54
RNA sequencing of prostate cancer and normal tissue from African Americans and European Americans 0.52
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 0.5
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 0.49
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.49
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 0.47
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 0.44
RNAseq transcriptome analysis of White Blood Cells (WBCs) from individuals with and without trisomy 21 0.42
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.38
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.38
Be1 and Be2 B cells are transcriptionally distinct 0.37
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 0.35
6mer seed toxicity in viral microRNAs 0.32
CSL RNA-Seq on HKC and SCC cell lines 0.31
CSL 0.31
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.3
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 0.28
Transcription elongation regulates genome 3D structure 0.27
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.25
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 0.23
Cancer-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 0.23
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.22
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 0.22
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.2
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 0.17
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.16
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.15
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.14
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.14
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.1
MHC Transcriptomic landscape at haplotype-specific resolution 0.1
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 0.09
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 0.04


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation